AMY BERRETTA: Open Payments
NPI 1497110696 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,485 in 132 payments from 15 companies in 2025. Trend: 2023 $1,126 · 2024 $2,227 · 2025 $2,485
Food & beverage: $2,485
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $769 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $546 |
| Axsome Therapeutics, Inc. | 8 | $320 |
| Supernus Pharmaceuticals, Inc. | 11 | $235 |
| Otsuka America Pharmaceutical, Inc. | 17 | $187 |
| Alkermes, Inc. | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: VRAYLAR, CAPLYTA, Auvelity, Qelbree, REXULTI, ABILIFY MAINTENA, BOTOX, ARISTADA.
Industry payments across NY — which companies pay providers there.
